A dedicated facility capable of small scale manufacture of active pharmaceutical ingredients for early stage clinical studies. The Active pharmaceutical ingredient (API) manufacturing Lab specialises in the manufacturing of drug products, method development, stability studies and supportive analytical services. To date, this facility has successfully manufactured 3 API’s for early-stage clinical studies and provided associated stability and analytical packages for these agents. Facilitating rapid translation into man by manufacturing in-house, mitigating the risks and costs associated with outsourced manufacture. This article was published on 2022-09-29
